BiotroniK

German medical technology company Biotronik has introduced its smallest MR conditional pacing lead, Solia S ProMRI in the US.

The Solia S ProMRI features a 5.6 French lead body structure and is available in three size configurations which are 45cm, 53cm and 60cm in length.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

University of California, San Diego School of Medicine professor of medicine and UC San Diego Health pacemaker and ICD services director Ulrika Birgersdotter-Green said: "Because there is a wide range of patient anatomy types, it is necessary to have various lead lengths to ensure the best outcomes.

"There have been, however, limitations in the variety of leads available, so this new technology will offer a more versatile lead and improve procedures."

"This new technology will offer a more versatile lead and improve procedures."

The MR conditional pacing lead is based on the ProMRI technology which enables the patients with pacemaker, implantable defibrillator, cardiac monitor, or cardiac resynchronisation therapy defibrillator (CRT-D) to undergo an MRI scan.

See Also:

The Solia S ProMRI is supplemented with a polyurethane coating over silicone which is intended to reduce friction while allowing an easier application of Solia through small vessels and complex anatomy.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Its soft distal segment is designed to help reduce stress and decrease myocardial trauma.

A pre-market study (IDE) phase of the SIELLO clinical study had tested 1,758 patients at 60 US sites with 3,220 implanted Solia leads and ascertained the primary safety and efficacy of the device.

Image: Biotronik’s Solia S ProMRI. Photo: courtesy of Biotronik.